The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, phase II study of ficlatuzumab with or without cetuximab in patients with pan-refractory, recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
 
Julie E. Bauman
Consulting or Advisory Role - AstraZeneca/MedImmune; CUE Biopharma; Merck Serono
Research Funding - AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Lilly (Inst); Moderna Therapeutics (Inst); Novartis (Inst)
 
Denise Roe
No Relationships to Disclose
 
Nabil F. Saba
Honoraria - Aduro Biotech; Bristol-Myers Squibb; CUE Biopharma; Genentech/Roche; GlaxoSmithKline; Kura Oncology; Lilly; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Lilly; Merck; Pfizer
 
Jessica Ruth Bauman
Consulting or Advisory Role - AstraZeneca; Bayer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Trident Pharmaceuticals
 
John M. Kaczmar
Consulting or Advisory Role - Regeneron
 
Barbara Burtness
Honoraria - AstraZeneca
Consulting or Advisory Role - Aduro Biotech; Alligator Bioscience; ALX Oncology; AstraZeneca; Bristol-Myers Squibb; Celgene; CUE Biopharma; Debiopharm Group; GlaxoSmithKline; Macrogenics; Maverick Therapeutics; Merck; Nanobiotix; Rakuten Medical
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Formation Biologics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Debiopharm Group; Merck
 
Jameel Muzaffar
No Relationships to Disclose
 
Ricklie Ann Julian
No Relationships to Disclose
 
Steven Wang
No Relationships to Disclose
 
Shethal Bearelly
No Relationships to Disclose
 
Audrey Baker
No Relationships to Disclose
 
Conor Ernst Steuer
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARMO BioSciences; BerGenBio; Lilly
Research Funding - Daiichi Sankyo; Infinity Pharmaceuticals; Seagen; Vaccinex
 
Aarti K. Bhatia
Research Funding - Boehringer Ingelheim
 
Anshu Giri
No Relationships to Disclose
 
Carlos Caulin
No Relationships to Disclose
 
Laura P. Stabile
No Relationships to Disclose
 
Sara Centuori
No Relationships to Disclose
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; CUE Biopharma; Ignyta; Mirati Therapeutics
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ignyta; IRX Therapeutics; Lilly; Lion Biotechnologies; Merck; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; Mirati Therapeutics